Section 906 Sarbanes-Oxley Act Certification by CEO and CFO of Oxygen Therapy, Inc. for Q3 2017
This document is a certification by the Chief Executive Officer and Chief Financial Officer of Oxygen Therapy, Inc. regarding the company's Quarterly Report for the period ending September 30, 2017. The officers confirm that, to their knowledge, the report complies with SEC requirements and fairly presents the company's financial condition and results. This certification is made in accordance with Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 2.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Oxygen Therapy, Inc. (the “Company”) for the quarter ending September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), David Platt, Chief Executive Officer and Ola Soderquist, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:
(1) The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: November 14, 2017 | By: | /s/ David Platt |
| David Platt | ||
| Chief Executive Officer | ||
| /s/ Ola Soderquist | ||
| Ola Soderquist | ||
| Chief Financial Officer |
